Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Age-Related Macular Degeneration and Neurodegenerative Disorders: Shared Pathways in Complex Interactions Publisher Pubmed



Jabbehdari S1 ; Oganov AC2 ; Rezagholi F3 ; Mohammadi S4 ; Harandi H4 ; Yazdanpanah G5 ; Arevalo JF6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, United States
  2. 2. Department of Ophthalmology, Renaissance School of Medicine, Stony Brook, NY, United States
  3. 3. School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
  4. 4. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, United States
  6. 6. Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD, United States

Source: Survey of Ophthalmology Published:2024


Abstract

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the elderly, and neurodegenerative disorders such as Alzheimer disease and Parkinson disease are debilitating conditions that affect millions worldwide. Despite the different clinical manifestations of these diseases, growing evidence suggests that they share common pathways in their pathogenesis including inflammation, oxidative stress, and impaired autophagy. In this review, we explore the complex interactions between AMD and neurodegenerative disorders, focusing on their shared mechanisms and potential therapeutic targets. We also discuss the current opportunities and challenges for developing effective treatments that can target these pathways to prevent or slow down disease progression in AMD. Some of the promising strategies that we explore include modulating the immune response, reducing oxidative stress, enhancing autophagy and lysosomal function, and targeting specific protein aggregates or pathways. Ultimately, a better understanding of the shared pathways between AMD and neurodegenerative disorders may pave the way for novel and more efficacious treatments. © 2023 Elsevier Inc.
Other Related Docs
14. Role of Natural Products for the Treatment of Alzheimer's Disease, European Journal of Pharmacology (2021)